| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.002 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.09 | 0.004 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.36 | 0.007 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.007 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.008 |